Mammogram
A mammogram is
an
X-ray test of the
breasts
(mammary glands) used to screen for breast
problems, such as a lump, and whether a lump is fluid-filled (a
cyst) or a solid mass.
A mammogram is done to help screen for or detect breast cancer. Many small tumors can be seen on a mammogram before they can be felt by a woman or her health professional. Cancer is most easily treated and cured when it is discovered in an early stage. Mammograms do not prevent breast cancer or reduce a woman's risk of developing cancer. But regular mammograms can reduce a woman's risk of dying from breast cancer by detecting a cancer when it is more easily treated.
Experts have different recommendations for how often you should have a mammogram. 1
- For women older than age 50, regular mammograms (every 1 to 2 years) are recommended.
- For women between the ages of 40 and 50, the benefits of mammogram are not as clear. Talk with your health professional to determine when to start and how often to have a mammogram. Some organizations recommend mammograms every 1 to 2 years while others recommend mammograms every year. Most organizations recommend that women have their first mammogram at age 40.
- Your health professional may recommend testing more often if you have risk factors for breast cancer. Any woman with a personal or family history of breast cancer is recommended to have yearly mammograms.
A mammogram that appears to detect a cancer, when in fact a cancer is not present ( false-positive results), can occur at any age but is more likely to occur in younger women. About 5% to 10% of screening mammograms will require more testing. This may include another mammogram of specific breast tissue (compression view) or another test, such as an ultrasound or biopsy. Most of these tests will show no cancer is present.
Why It Is Done
A mammogram is done to:
- Screen for breast cancer in women without symptoms.
- Detect breast cancer in women with symptoms. Symptoms of breast cancer may include a lump or thickening in the breast, nipple discharge, or dimpling of the skin on one area of the breast.
- Locate an area of suspicious breast tissue to remove for examination under a microscope (biopsy) when an abnormality is found.
WebMD Medical Reference from Healthwise
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

